Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Frappaz

Showing results (181-190 of 189) with videos related to

Pageof 19
Sort By:
You have reached the last page of results.This site can display upto 189 results.
Neuropathology and Applied Neurobiology|June 24, 2011
Utility of Ki67 immunostaining in the grading of pineal parenchymal tumours: a multicentre studyM Fèvre-Montange, A Vasiljevic, D Frappaz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 25, 2003
European Organization for Research and Treatment of Cancer (EORTC) open label phase II study on glufosfamide administered as a 60-minute infusion every 3 weeks in recurrent glioblastoma multiformeM J van den Bent, W Grisold, D Frappaz, et al.
European Journal of Cancer (Oxford, England : 1990)|September 8, 2006
Treatment of high risk medulloblastomas in children above the age of 3 years: a SFOP studyJ Verlooy, V Mosseri, S Bracard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1997
N-Myc gene amplification is a major prognostic factor in localized neuroblastoma: results of the French NBL 90 study. Neuroblastoma Study Group of the Société Francaise d'Oncologie PédiatriqueH Rubie, O Hartmann, J Michon, et al.
Neuropathology and Applied Neurobiology|January 6, 2017
Rhabdoid component emerging as a subclonal evolution of paediatric glioneuronal tumoursA Bertrand, C Rondenet, J Masliah-Planchon, et al.
British Journal of Cancer|August 14, 2003
Summary version of the Standards, Options and Recommendations for the management of adult patients with intracranial glioma (2002)D Frappaz, O Chinot, A Bataillard, et al.
Bulletin Du Cancer|July 19, 2001
[Li-Fraumeni syndrome: update, new data and guidelines for clinical management]T Frebourg, A Abel, C Bonaiti-Pellie, et al.
European Journal of Cancer (Oxford, England : 1990)|March 28, 1998
The International Neuroblastoma Risk Groups (INRG): a preliminary reportR P Castleberry, J Pritchard, P Ambros, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 14, 2019
Molecular screening program to select molecular-based recommended therapies for metastatic cancer patients: analysis from the ProfiLER trialO Trédan, Q Wang, D Pissaloux, et al.
Pageof 19

Showing results (181-190 of 189) with videos related to

Sort By:
Pageof 19
You have reached the last page of results.This site can display upto 189 results.
Neuropathology and Applied Neurobiology|June 24, 2011
Utility of Ki67 immunostaining in the grading of pineal parenchymal tumours: a multicentre studyM Fèvre-Montange, A Vasiljevic, D Frappaz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 25, 2003
European Organization for Research and Treatment of Cancer (EORTC) open label phase II study on glufosfamide administered as a 60-minute infusion every 3 weeks in recurrent glioblastoma multiformeM J van den Bent, W Grisold, D Frappaz, et al.
European Journal of Cancer (Oxford, England : 1990)|September 8, 2006
Treatment of high risk medulloblastomas in children above the age of 3 years: a SFOP studyJ Verlooy, V Mosseri, S Bracard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1997
N-Myc gene amplification is a major prognostic factor in localized neuroblastoma: results of the French NBL 90 study. Neuroblastoma Study Group of the Société Francaise d'Oncologie PédiatriqueH Rubie, O Hartmann, J Michon, et al.
Neuropathology and Applied Neurobiology|January 6, 2017
Rhabdoid component emerging as a subclonal evolution of paediatric glioneuronal tumoursA Bertrand, C Rondenet, J Masliah-Planchon, et al.
British Journal of Cancer|August 14, 2003
Summary version of the Standards, Options and Recommendations for the management of adult patients with intracranial glioma (2002)D Frappaz, O Chinot, A Bataillard, et al.
Bulletin Du Cancer|July 19, 2001
[Li-Fraumeni syndrome: update, new data and guidelines for clinical management]T Frebourg, A Abel, C Bonaiti-Pellie, et al.
European Journal of Cancer (Oxford, England : 1990)|March 28, 1998
The International Neuroblastoma Risk Groups (INRG): a preliminary reportR P Castleberry, J Pritchard, P Ambros, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 14, 2019
Molecular screening program to select molecular-based recommended therapies for metastatic cancer patients: analysis from the ProfiLER trialO Trédan, Q Wang, D Pissaloux, et al.
Pageof 19